共 37 条
[1]
Brilla, Pick, Tan, Janicki, Weber, Remodelling of the rat right and left ventricle in experimental hypertension, Circ Res, 67, pp. 1355-1364, (1990)
[2]
Linz, Schaper, Wiemer, Albus, Scholkens, Ramipril prevents left ventricular hypertrophy with myocardial fibrosis without blood pressure reduction: a one year study in rats, Br J Pharmacol, 107, pp. 970-975, (1992)
[3]
Linz, Scholkens, Ganien, Converting enzyme inhibition specifically prevents the development and induces the regression of cardiac hypertrophy in rats, Clin Exp Hypertens, 11, 7, pp. 1325-1350, (1989)
[4]
Tiret, Rigat, Visvikis, Et al., Evidence from combined segregation analysis that a variant of the angiotensin I-converting enzyme (ACE) gene controls plasma ACE levels, Am J Hum Genet, 51, pp. 197-205, (1992)
[5]
Cambien, Poirier, Lecerf, Et al., Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction, Nature, 359, pp. 641-644, (1992)
[6]
Tiret, Kee, Poirer, Et al., Deletion polymorphism in angiotensin-converting enzyme gene associated with parental history of myocardial infarction, Lancet, 341, pp. 991-992, (1993)
[7]
Raynolds, Bristow, Bash, Et al., Angiotensin-converting enzyme DD genotype in patients with ischaemic or idiopathic dilated cardiomyopathy, Lancet, 342, pp. 1073-1075, (1993)
[8]
Woodrow, Circulating ACE concentrations and progression of heart disease [letter], Lancet, pp. 343-353, (1994)
[9]
Rigat, Hubert, Alhenc-Gelas, Cambien, Corvol, Soubrier, An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels, J Clin Invest, 86, pp. 1343-1346, (1990)
[10]
Brandenberg, Chazov, Cherian, Et al., Report of the WHO/ISFC Task Force on Definition and Classification of the Cardiomyopathies, Circulation, 64, pp. 1397-1399, (1981)